{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-035781","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2022-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.464909+00:00","generated_at":"2026-06-21T03:13:19.359208+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Dare Bioscience receives Nasdaq deficiency notice for stock price below $1.00","bullets":["Nasdaq notified Dare on Dec 16, 2022 that its common stock closed below $1.00 for 30 consecutive business days.","The company has 180 calendar days, until June 14, 2023, to regain compliance with the minimum bid price rule.","Compliance can be achieved if closing bid price is at least $1.00 for 10 consecutive business days.","If not compliant by June 14, 2023, Dare may be eligible for an additional 180-day period subject to meeting other standards.","Failure to regain compliance could result in delisting from Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-035781","json":"https://secwatch.observer/filing/0001493152-22-035781.json","markdown":"https://secwatch.observer/filing/0001493152-22-035781.md","text":"https://secwatch.observer/filing/0001493152-22-035781.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000149315222035781/0001493152-22-035781-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000149315222035781/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T03:13:19.359208+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a78be2747a26790a691d1e35d11ccd4f9ca9a63f","claim":"Dare Bioscience, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"December 16, 2022, Daré Bioscience, Inc. (“Daré”) received a letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying Daré that, for the last 30 consecutive business days, the closing bid price for Daré’s common stock was below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Nasdaq letter has no immediate effect on the listing of Daré’s common stock on the Nasdaq Capital Market. In accordance with Nasdaq list","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315222035781/0001493152-22-035781-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}